To summarize, altered CD8+, CD19+ and NK cell levels may be used as reference values for monitoring the immune function of certain populations with high HCC risk, and as evidence for the clinical diagnosis and treatment of HCC. Here, CD8A is linked to hepatocellular carcinoma.